Abvc Biopharma Stock Market Value
| ABVC Stock | USD 1.89 0.13 6.44% |
| Symbol | ABVC |
Will Biotechnology sector continue expanding? Could ABVC diversify its offerings? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ABVC Biopharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.28) | Revenue Per Share | Quarterly Revenue Growth 1.045 | Return On Assets | Return On Equity |
Understanding ABVC Biopharma requires distinguishing between market price and book value, where the latter reflects ABVC's accounting equity. The concept of intrinsic value—what ABVC Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push ABVC Biopharma's price substantially above or below its fundamental value.
Understanding that ABVC Biopharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ABVC Biopharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, ABVC Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
ABVC Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ABVC Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ABVC Biopharma.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in ABVC Biopharma on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding ABVC Biopharma or generate 0.0% return on investment in ABVC Biopharma over 90 days. ABVC Biopharma is related to or competes with Reviva Pharmaceuticals, Grace Therapeutics, PDS Biotechnology, Actinium Pharmaceuticals, Jupiter Neurosciences, Tvardi Therapeutics, and Lantern Pharma. ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet me... More
ABVC Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ABVC Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ABVC Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 17.75 | |||
| Value At Risk | (6.44) | |||
| Potential Upside | 6.44 |
ABVC Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ABVC Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ABVC Biopharma's standard deviation. In reality, there are many statistical measures that can use ABVC Biopharma historical prices to predict the future ABVC Biopharma's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (0.83) | |||
| Treynor Ratio | (0.88) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ABVC Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ABVC Biopharma February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | (0.87) | |||
| Mean Deviation | 3.12 | |||
| Coefficient Of Variation | (683.43) | |||
| Standard Deviation | 3.93 | |||
| Variance | 15.44 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (0.83) | |||
| Treynor Ratio | (0.88) | |||
| Maximum Drawdown | 17.75 | |||
| Value At Risk | (6.44) | |||
| Potential Upside | 6.44 | |||
| Skewness | (0.11) | |||
| Kurtosis | 0.1234 |
ABVC Biopharma Backtested Returns
ABVC Biopharma secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16 % return per unit of volatility over the last 3 months. ABVC Biopharma exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ABVC Biopharma's Market Risk Adjusted Performance of (0.87), mean deviation of 3.12, and Variance of 15.44 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.67, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ABVC Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding ABVC Biopharma is expected to be smaller as well. At this point, ABVC Biopharma has a negative expected return of -0.62%. Please make sure to confirm ABVC Biopharma's potential upside, as well as the relationship between the rate of daily change and price action indicator , to decide if ABVC Biopharma performance from the past will be repeated in the future.
Auto-correlation | 0.79 |
Good predictability
ABVC Biopharma has good predictability. Overlapping area represents the amount of predictability between ABVC Biopharma time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ABVC Biopharma price movement. The serial correlation of 0.79 indicates that around 79.0% of current ABVC Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.79 | |
| Spearman Rank Test | 0.81 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ABVC Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ABVC Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Abvc Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Abvc Biopharma Stock:Check out ABVC Biopharma Correlation, ABVC Biopharma Volatility and ABVC Biopharma Performance module to complement your research on ABVC Biopharma. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
ABVC Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.